Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis
PDF
Cite
Share
Request
Letter to Editor
P: 373-374
September 2016

Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis

J Clin Res Pediatr Endocrinol 2016;8(3):373-374
1.
2.
3. Intergen Genetics Center, Clinic Of Medical Genetics, Ankara, Turkey
No information available.
No information available
Received Date: 04.05.2016
Accepted Date: 10.05.2016
Publish Date: 01.09.2016
PDF
Cite
Share
Request

Dear Editor,

Crouzonodermoskeletal syndrome) [Online Mendelian Inheritance in Man (OMIM) ID no. 612247] or Crouzon syndrome with acanthosis nigricans (CSAN) is a clinically and genetically distinct entity from the classic Crouzon syndrome (1). While classic Crouzon syndrome is caused by mutation in the FGFR3 gene, CSAN is caused by only mutation p.A391E in the FGFR3 gene. Other FGFR3 gene mutations are not responsible of this syndrome, and they usually lead to hypochondroplasia or achondroplasia but not CSAN (2,3). Clinically, in addition to classic Crouzon syndrome, patients with CSAN have acanthosis nigricans and skeletal abnormalities (1,4). The phenotypic features include wide-set bulging eyes and underdeveloped upper jaw, craniosynostosis, midface hypoplasia, hypertelorism, proptosis, posteriorly rotated ears, and in some cases, hearing loss. Patients with CSAN often present with choanal atresia and hydrocephalus (4).

A ten-month-old girl presented with a facial dysmorphia at birth. There was no consanguinity between her parents. She was born at term weighing 3380 g with no perinatal complications. She had obstructive dyspnea at day 1 due to bilateral choanal atresia for which she was operated at day 9. At 9 months of age, she had coronal craniectomy surgery because of craniosynostosis due to bilateral coronal stenosis.

At presentation, her height was 68.7 cm [-1.13 standard deviation score (SDS)] and weight was 7.3 kg (-1.97 SDS). She had atypical facial features (midface hypoplasia, hypertelorism, craniosynostosis, brachycephaly, maxillary hypoplasia, exophthalmos, bilateral distinctive and low-set ears), lateral nystagmus on the bilateral eyes, and widespread acanthosis nigricans on all of curve regions as neck, bilateral axillae (Figure 1). Cranial magnetic resonance imaging (MRI) revealed hydrocephalus, hypoplasia of corpus callosum and inferior vermis (Figure 2). There was no pathology at abdominal ultrasonography and echocardiography. The audiogram did not reveal any pathology. The cognitive and motor development were delayed.

We detected a de novo heterozygous A391E (c.1172C>A) mutation in FGFR3 gene in our patient. This syndrome is inherited in an autosomal dominant type although most cases are sporadic mutations (5). We detected the mutation in the patient but not in her parents and sisters (Figure 3). Therefore, our patient is a sporadic form of CSAN.

As with other disorders caused by FGFR gene mutations, increased paternal age seems to be a risk factor (1). Our patient’s father age was 42 years old.

To our knowledge, this is the first case of CSAN with hypoplasia of corpus callosum and inferior vermis. This association may be coincidental. These patients should be investigated for other possible cranial MRI findings.

Ethics

Peer-review: Internal peer-reviewed.

Authorship Contributions

Concept: Fatih Gürbüz, Ali Kemal Topaloğlu, Bilgin Yüksel, Design: Fatih Gürbüz, Ali Kemal Topaloğlu, Bilgin Yüksel, Data Collection or Processing: Fatih Gürbüz, Ali Kemal Topaloğlu, Bilgin Yüksel, Analysis or Interpretation: Fatih Gürbüz, Serdar Ceylaner, Ali Kemal Topaloğlu, Bilgin Yüksel, Literature Search: Fatih Gürbüz, Ali Kemal Topaloğlu, Bilgin Yüksel, Writing: Fatih Gürbüz, Ali Kemal Topaloğlu, Bilgin Yüksel.

Conflict of Interest: None declared.

Financial Disclosure: The authors declared that this study has received no financial support.